Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Ertugliflozin manufacturers

Filters

Filters

Filters , active

Country of origin : Pakistan

Clear all

None products found

ertugliflozin + sitagliptin

Tablets 5 mg + 100 mg, 15 mg + 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, PICS
Manufacturer #21118

This CTD dossier owner and manufacturer is a pharmaceutical manufacturer with a strong commitment to quality and safety. Their products include solid dosage forms like tablets, capsules, sachets, and dry powder suspensions. They focus on research and development, utilizing cutting-edge technologies to meet international standards. The company holds cGMP certifications from the Pharmaceutical Inspection Convention (PIC/s) and has a dedicated team of researchers and regulatory experts. While they operate globally with a presence in diverse regions like the EU and North America, specific therapy areas and product patents are not mentioned.

Manufacturer usually replies in 43 days

ertugliflozin + sitagliptin

Tablets 5 mg + 100 mg, 15 mg + 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #19907

This company is a global pharmaceutical manufacturer with a focus on providing high-quality, affordable branded generic formulations. They have a strong track record spanning over 25 years, evident in their flagship brand's longevity. Their production lines encompass prescription medications, over-the-counter drugs, and supplements, catering to diverse therapeutic areas such as cardiology, gastroenterology, and central nervous system disorders. The company prioritizes quality control and assurance, adhering to strict GMP certifications. They have a presence in over 50 countries across regions like North America and the EU. Their commitment to innovation is demonstrated by their continuous investments in research and development, leading to several product patents.

ertugliflozin + metformin

Tablets 2.5 mg + 500 mg, 2.5 mg + 850 mg, 2.5 mg + 1000 mg, 7.5 mg + 500 mg, 7.5 mg + 850 mg, 7.5 mg + 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #19907

This company is a global pharmaceutical manufacturer with a focus on providing high-quality, affordable branded generic formulations. They have a strong track record spanning over 25 years, evident in their flagship brand's longevity. Their production lines encompass prescription medications, over-the-counter drugs, and supplements, catering to diverse therapeutic areas such as cardiology, gastroenterology, and central nervous system disorders. The company prioritizes quality control and assurance, adhering to strict GMP certifications. They have a presence in over 50 countries across regions like North America and the EU. Their commitment to innovation is demonstrated by their continuous investments in research and development, leading to several product patents.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.